These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23092281)

  • 1. Quinoline-based HIV integrase inhibitors.
    Musiol R
    Curr Pharm Des; 2013; 19(10):1835-49. PubMed ID: 23092281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review on Quinoline Derived Scaffolds as Anti-HIV Agents.
    Chokkar N; Kalra S; Chauhan M; Kumar R
    Mini Rev Med Chem; 2019; 19(6):510-526. PubMed ID: 30338737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Design, synthesis of quinolinone acid-containing compounds with anti-HIV integrase activity].
    Chen XF; Wu YB; Jin J; Wang RZ; Wang C; Liu J
    Yao Xue Xue Bao; 2010 Feb; 45(2):263-7. PubMed ID: 21351438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.
    Vandurm P; Guiguen A; Cauvin C; Georges B; Le Van K; Michaux C; Cardona C; Mbemba G; Mouscadet JF; Hevesi L; Van Lint C; Wouters J
    Eur J Med Chem; 2011 May; 46(5):1749-56. PubMed ID: 21385662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of the Morita-Baylis-Hillman reaction in the synthesis of 3-[(N-cycloalkylbenzamido)methyl]-2-quinolones as potential HIV-1 integrase inhibitors.
    Sekgota KC; Majumder S; Isaacs M; Mnkandhla D; Hoppe HC; Khanye SD; Kriel FH; Coates J; Kaye PT
    Bioorg Chem; 2017 Dec; 75():310-316. PubMed ID: 29080495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolone 3-carboxylic acid pharmacophore: design of second generation HIV-1 integrase inhibitors.
    Dayam R; Al-Mawsawi LQ; Zawahir Z; Witvrouw M; Debyser Z; Neamati N
    J Med Chem; 2008 Mar; 51(5):1136-44. PubMed ID: 18281931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elvitegravir: a new HIV integrase inhibitor.
    Shimura K; Kodama EN
    Antivir Chem Chemother; 2009 Oct; 20(2):79-85. PubMed ID: 19843978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, practical synthesis, and biological evaluation of novel 6-(pyrazolylmethyl)-4-quinoline-3-carboxylic acid derivatives as HIV-1 integrase inhibitors.
    Hu L; Yan S; Luo Z; Han X; Wang Y; Wang Z; Zeng C
    Molecules; 2012 Sep; 17(9):10652-66. PubMed ID: 22955454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substituted 2-pyrrolinone inhibitors of HIV-1 integrase.
    Dayam R; Al-Mawsawi LQ; Neamati N
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6155-9. PubMed ID: 17911021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore and structure-activity relationships of integrase inhibition within a dual inhibitor scaffold of HIV reverse transcriptase and integrase.
    Wang Z; Tang J; Salomon CE; Dreis CD; Vince R
    Bioorg Med Chem; 2010 Jun; 18(12):4202-11. PubMed ID: 20576573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of integrase inhibitors of quinolone acid derivatives for treatment of AIDS: an overview.
    Luo ZG; Tan JJ; Zeng Y; Wang CX; Hu LM
    Mini Rev Med Chem; 2010 Oct; 10(11):1046-57. PubMed ID: 21044030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
    Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CoMFA and CoMSIA 3D-QSAR studies on quionolone caroxylic acid derivatives inhibitors of HIV-1 integrase.
    Lu P; Wei X; Zhang R
    Eur J Med Chem; 2010 Aug; 45(8):3413-9. PubMed ID: 20488589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinoline-based Protein-protein Interaction Inhibitors of LEDGF/p75 and HIV Integrase: An In Silico Study.
    Chhokar N; Kalra S; Chauhan M; Munshi A; Kumar R
    Curr Top Med Chem; 2018; 18(32):2800-2815. PubMed ID: 30747071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QSAR studies of HIV-1 integrase inhibition.
    Yuan H; Parrill AL
    Bioorg Med Chem; 2002 Dec; 10(12):4169-83. PubMed ID: 12413870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
    Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermolecular interactions in the crystal structures of potential HIV-1 integrase inhibitors.
    Majerz-Maniecka K; Musiol R; Nitek W; Oleksyn BJ; Mouscadet JF; Le Bret M; Polanski J
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1005-9. PubMed ID: 16289813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing HIV integrase inhibitors--shooting the last arrow.
    Makhija MT
    Curr Med Chem; 2006; 13(20):2429-41. PubMed ID: 16918363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-diketo acid pharmacophore hypothesis. 1. Discovery of a novel class of HIV-1 integrase inhibitors.
    Dayam R; Sanchez T; Clement O; Shoemaker R; Sei S; Neamati N
    J Med Chem; 2005 Jan; 48(1):111-20. PubMed ID: 15634005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of HIV-1 integrase inhibitors: pharmacophore mapping, virtual screening, molecular docking, synthesis, and biological evaluation.
    Bhatt H; Patel P; Pannecouque C
    Chem Biol Drug Des; 2014 Feb; 83(2):154-66. PubMed ID: 23957390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.